1. Hong Kong Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Alibaba Health Information Technology Limited

Alibaba Health Information Technology Limited

ALBHF
Alibaba Health Information Technology LimitedUS flagOther OTC
0.58
USD
+0.16
- -
9.40BMarket Cap
Alibaba Health Information Technology Limited
ALBHF
(Other OTC)

Recent

price

0.58

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
0.08
0.11
- -
0.01
- -
0.01
0.06
0.27
0.46
0.8
1.17
1.53
1.98
1.92
1.9
- -
Revenue per Share
-0.01
- -
-0.01
-0.01
-0.01
-0.02
-0.03
-0.01
-0.01
- -
0.03
-0.02
0.04
0.06
0.09
- -
Basic EPS, GAAP
-0.01
- -
- -
- -
-0.01
-0.02
-0.03
-0.01
0.04
0.05
0.07
0.03
0.02
0.08
0.09
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
-0.07
-0.09
-0.05
0.01
0.09
- -
Book Value per Share
0.08
0.08
0.05
0.07
0.16
0.14
0.13
0.27
0.25
0.43
1.07
0.96
1.04
0.96
0.95
- -
Tangible Book Value per Share
3,718
3,718
3,718
3,718
7,810
8,173
8,179
9,188
11,055
11,931
13,246
13,483
13,503
14,044
16,071
- -
Basic Weighted Avg Shares
314
391
13
22
30
57
475
2,443
5,096
9,596
15,518
20,578
26,763
27,027
30,598
34,255
Sales/Revenue/Turnover
-8.4
-6.97
-268.84
-164.1
-440.87
-372.37
-41.66
-5.29
-1.83
-0.44
0.71
-4.95
0.19
2.64
5.15
5.52
Operating Margin (%)
23
23
14
5
8
4
5
5
4
42
40
61
64
54
58
53
Depreciation Expense
-22
-6
-33
-31
-81
-192
-208
-107
-82
-7
349
-266
536
883
1,432
1,936
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
272.6
14.59
- -
2.63
5.99
8.2
14.86
Effective Tax Rate (%)
-7.08
-1.61
-260.21
-142.61
-273.07
-338.56
-43.7
-4.38
-1.61
-0.07
2.25
-1.29
2
3.27
4.68
5.65
Profit Margin (%)
116
61
39
109
1,112
850
457
1,436
70
2,403
10,799
8,743
9,476
8,487
7,534
10,329
Working Capital
- -
- -
- -
- -
- -
- -
200
- -
- -
38
17
85
40
48
25
30
LT Debt
340
324
230
282
1,267
1,155
1,120
2,523
2,737
5,203
14,282
14,070
15,147
14,518
16,313
17,857
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.5
0.97
- -
0.34
4.48
9.3
9.35
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-3.82
-96.35
- -
-61.62
-366.85
169.84
79.77
Return on Capital (%)
- -
-20.41
-110.41
-94.02
-148.73
-265
-286.8
-134.48
-86.48
-6.3
309.9
- -
- -
- -
179.27
81.36
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
41.92%
4.77%
9.46%
Free Cash Flow
-23.39%
48.98%
-10.79%
Net Income, GAAP
-586.4%
-63.13%
35.17%
Sales/Revenue/Turnover
150.1%
17.76%
11.95%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
27,027
2025
- -
- -
- -
- -
30,598
2026
- -
- -
- -
- -
34,255

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.06
2025
- -
- -
- -
- -
0.09
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Orexo AB (publ) (ORXOY)
Enorama Pharma AB (publ) (ERMA.ST)
PCI Biotech Holding ASA (0JGL.L)
JW Lifescience Corporation (234080.KS)
Komipharm International Co., Ltd. (041960.KQ)
FusionPharm, Inc. (FSPM)
Business
Alibaba Health Information Technology Limited (ALBHF) is an investment holding company and the flagship healthcare platform of Alibaba Group, providing integrated online and offline medical and healthcare solutions primarily in Mainland China and Hong Kong. The company engages in pharmaceutical direct sales, pharmaceutical e-commerce platforms, and healthcare and digital services, offering prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and other health-related items through self-operated B2C retail, Tmall Healthcare Platform with over 97 million SKUs from more than 56,000 merchants, and offline pharmacy outlets accessible via Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark; it also delivers medical and healthcare services such as medical checkups, consultations, appointment booking, vaccination, dental and mental care, optometry, nursing, and traditional Chinese medicine via internet hospitals and over 250,000 contracted licensed professionals, alongside digital tracking via the "Ma Shang Fang Xin" platform for pharmaceuticals, medical devices, and consumables. Incorporated in 1998 and headquartered in Causeway Bay, Hong Kong, the company, formerly CITIC 21CN Company Limited, rebranded to Alibaba Health Information Technology Limited in September 2014. In recent developments, Alibaba Health reported interim revenue of RMB16.7 billion and net profit of RMB1.3 billion for the six months ended September 30, 2025, reflecting 17% and 65% year-on-year growth, respectively, driven by 19% expansion in pharmaceutical direct sales to RMB14.4 billion; it formed strategic partnerships including a comprehensive agreement with United Imaging Microelectronics in April 2025 for medical-grade hearing aids, collaborations with Innovent Biologics in August 2025 for Mazdutide disease management and supply chain, and with Simcere Pharmaceutical in September 2025 for Daridorexant insomnia solutions, while Alibaba Group issued HK$12 billion in exchangeable bonds into Alibaba Health shares in July 2025 and the company advanced AI applications in e-commerce and clinical care.

Company News

APIChatGPT

  • defenseworld.net

    Alibaba Health Information Technology (OTC:ALBHF) Shares Down 6.4% – What’s Next?

  • defenseworld.net

    Alibaba Health Information Technology (OTC:ALBHF) Shares Up 2.1% – Here’s What Happened

  • defenseworld.net

    Alibaba Health Information Technology (OTC:ALBHF) Shares Down 5.1% – Here’s Why